Know who’s drifting before therapy stops.
Keel is a Speciality therapy intelligence platform that connects pharmacy, specialty pharmacy, benefits, and clinical signals into one continuous patient trajectory, helping teams recognize emerging therapy risk while there is still time to act.
Human-reviewed · Explainable
Refill history, benefit changes, specialty-pharmacy activity, and clinical context often sit in separate systems. By the time discontinuation becomes obvious, the opportunity to intervene may already be smaller.
The refill starts slipping.
The patient’s cost changes.
The expected activity disappears.
The context remains disconnected.
No single signal tells the story.
Keel connects the change across them.
One patient.Four fragmented views.
Keel brings therapy-related signals together without asking clinical teams to reconstruct the story manually.
Risk should appearbefore the lapse does.
Keel watches how the trajectory changes across time instead of waiting for one event to cross a static threshold.
- Recognize meaningful changes across signals
- Prioritize patients whose trajectory is deteriorating
- Preserve the evidence behind every risk change
LIVE DEMO CONSOLE · SYNTHETIC DEMONSTRATION DATA
Keel can surface risk, reconstruct the patient trajectory, and prepare the next step. The clinical team decides whether anything happens.
Keel prepares the step. A licensed clinician decides whether it happens — and that decision is written back to the patient’s record.
Measure whetherthe trajectory changed.
ILLUSTRATIVE OUTCOME MODEL
Modelled on synthetic demonstration data. Shown for shape, not magnitude — a difference between these paths would be an association, not evidence that any intervention caused it.
Trust has to existbefore intervention does.
Keel is designed to keep evidence visible, actions reviewable, and consequential decisions with authorized teams.
SECURITY AND GOVERNANCE BY DESIGN. DESIGNED FOR GOVERNED CLINICAL WORKFLOWS — NO CERTIFICATION OR REGULATORY CLEARANCE IS CLAIMED.
Read the governance model →Consequential interventions stay reviewable.
Risk drivers remain visible.
Every relevant signal retains its source.
Reviews and actions remain traceable.
Sensitive workflows are role-scoped.
Performance can be evaluated across populations.
One trajectory.Different decisions.
See where therapy continuity is breaking.
- Population-level risk movement
- Program-level intervention visibility
- Operational bottlenecks
Built around the systemsyou already depend on.
Keel is designed to bring therapy-continuity signals together without asking teams to replace their systems of record.
Hover a source category to trace its path. Categories describe the kinds of data Keel is designed to organize; no specific production integration is claimed.
Explore how Keel turns fragmented therapy signals into one continuous patient trajectory.
CONCEPT PRODUCT · SYNTHETIC DEMONSTRATION DATA